Quaker Partners

The record

Every round we can evidence, newest first58 appearances

1. 2019

   2 rounds

2. May
   Intact VascularUS · Massdevice$25MWith 3 others
3. May
   Vesper MedicalUS · Massdevice$37MWith 3 others
4. 2018

   2 rounds

5. May
   VesperSeries A · US · Fiercebiotech$11MWith 1 other
6. May
   Rapid MicroUS · FinSMEs$60MWith 6 others
7. 2017

   1 round

8. Jan
   Intact VascularSeries B · US · FinSMEs$7.1MWith 1 other
9. 2015

   3 rounds

10. May
    Intact VascularSeries B · US$38MWith 2 others
11. Apr
    Rapid Micro BiosystemsSeries C · US$25MWith 5 others
12. Apr
    NeuroneticsSeries F · US$34MWith 7 others
13. 2014

    2 rounds

14. May
    Tarsa TherapeuticsSeries B · US$7.0MWith 3 others
15. Apr
    Rapid Micro BiosystemsVenture · US$6.0MWith 4 others
16. 2013

    3 rounds

17. Sept
    PreCision DermatologyDebt · US · pehub.com$67MWith 7 others
18. Jun
    Rapid Micro BiosystemsSeries B · US · finsmes.com$33MWith 4 others
19. Apr
    RainDance TechnologiesSeries E · US · finsmes.com$20MWith 4 others
20. 2012

    3 rounds

21. Dec
    Regado BiosciencesSeries E · US · regadobio.investorroom.com$51MWith 8 others
22. Sept
    Intact VascularSeries A · US · intactvascular.com$16MWith 1 other
23. Mar
    Tarsa TherapeuticsSeries B · US · prnewswire.com$28MWith 4 others
24. 2011

    3 rounds

25. Jun
    NovaSomSeries D · US · novasom.com$35MWith 2 others
26. May
    NeuroneticsSeries E · US · marketwire.com$30MWith 7 others
27. Jan
    RainDance TechnologiesSeries D · US · finsmes.com$38MWith 3 others
28. 2010

    7 rounds

29. Sept
    Celator PharmaceuticalsSeries D · US · celatorpharma.com$20MWith 6 others
30. Aug
    Achillion PharmaceuticalsVenture · US · ir.achillion.com$50MWith 3 others
31. Aug
    TetraLogic PharmaceuticalsSeries C · US · fiercebiotech.com$32MWith 7 others
32. Jun
    Corridor PharmaceuticalsSeries A · US · finance.yahoo.com$13MWith 7 others
33. May
    TearScienceSeries C · US · onbiovc.com$45MWith 5 others
34. Jan
    Tarsa TherapeuticsSeries A · US · onbiovc.com$24MWith 2 others
35. Jan
    BioLeapSeries A · US · eon.businesswire.com$5.0MWith 1 other
36. 2009

    7 rounds

37. Dec
    Regado BiosciencesSeries D · US · regadobio.com$40MWith 5 others
38. Oct
    Sleep SolutionsSeries F · US · onbiovc.com$20MWith 5 others
39. Oct
    NeuroneticsSeries D · US · onbiovc.com$30MWith 7 others
40. Oct
    TransEnterixSeries B · US · onbiovc.com$55MWith 5 others
41. Oct
    Corridor PharmaceuticalsSeries A · US · venturedeal.com$11MWith 3 others
42. Aug
    Rapid Micro BiosystemsSeries A · US · onbiovc.com$19MWith 3 others
43. Jun
    CempraSeries C · US · onbiovc.com$46MWith 5 others
44. 2008

    6 rounds

45. Nov
    TengionSeries C · US$21MWith 7 others
46. Oct
    Seed · findarticles.com$2.3MWith 3 others
47. Oct
    Corridor PharmaceuticalsSeed · US · findarticles.com$2.3MWith 3 others
48. Oct
    Biolex TherapeuticsSeries D · US · mitsuiventures.com$60MWith 10 others
49. Jul
    Celator PharmaceuticalsSeries C · US$23MWith 5 others
50. Jul
    NuPatheSeries B · US$30MWith 6 others
51. 2007

    9 rounds

52. Nov
    TranzymeVenture · US$20MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration3 named

We also hold 6 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed6 in all

An exit counts when it came after the firm's first round in the company. From historical deal records.